Kelman-Lazarov Inc’s MetLife MET Stock Holding History

Kelman-Lazarov Inc’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,061	Closed	-$215K	–	87
2022 Q1	$215K	Buy	+3,061	New	+$207K	0.07%	80

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kelman-Lazarov Inc's MET Position: Q2 2022 in Review

Kelman-Lazarov Inc sold out of MetLife (MET) in Q2 2022, closing a stake of 3,061 shares — an estimated $215K sold.

Kelman-Lazarov Inc first reported a position in MET in Q1 2022 and held it in 1 quarter. The position peaked at $215K in Q1 2022. 1,198 funds tracked by Wall St. Rank hold MET as of Q2 2022.

Kelman-Lazarov Inc reported no remaining MetLife position as of Q2 2022 after selling out during the quarter.
Kelman-Lazarov Inc sold 3,061 MetLife shares in Q2 2022, an estimated $215K.
Kelman-Lazarov Inc first reported a position in MetLife in Q1 2022 and held it in 1 quarter.
Kelman-Lazarov Inc's MetLife position peaked at $215K in Q1 2022.
1,198 funds tracked by Wall St. Rank held MetLife as of Q2 2022.

Based on Kelman-Lazarov Inc's 13F filing for Q2 2022, filed 8 Aug 2022.